- Home
- TIL vs HFBL Comparison
TIL vs HFBL Comparison
Compare TIL & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TIL | HFBL |
|---|---|---|
| Founded | 2018 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.8M | 60.2M |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | TIL | HFBL |
|---|---|---|
| Price | $8.15 | $19.68 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $125.00 | N/A |
| AVG Volume (30 Days) | ★ 20.2K | 2.6K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 2.83% |
| EPS Growth | 6.06 | ★ 7.69 |
| EPS | N/A | ★ 1.07 |
| Revenue | N/A | ★ $1,303,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.79 |
| Revenue Growth | N/A | ★ 17.49 |
| 52 Week Low | $5.67 | $12.32 |
| 52 Week High | $42.75 | $20.30 |
Technical Indicators
Market Signals| Indicator | TIL | HFBL |
|---|---|---|
| Relative Strength Index (RSI) | 45.68 | 58.30 |
| Support Level | $7.59 | $18.02 |
| Resistance Level | $8.30 | $20.15 |
| Average True Range (ATR) | 0.26 | 0.33 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 57.48 | 72.81 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.